Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

about

Timing of androgen receptor disruption and estrogen exposure underlies a spectrum of congenital penile anomalies.The inconspicuous penis in children.

P2860

Q36435412-E83F6D47-D545-4A21-B0DA-DA899126980A Q38410086-2698F10A-1CE4-4FB1-8573-8DBD519EF68F

P2860

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

Item

http://www.wikidata.org/entity/Q38034398

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

@en

type

Item

label

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

@en

prefLabel

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

@en

P1476

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

@en

P2093

David Ralph

http://www.w3.org/2001/XMLSchema#string

Majid Shabbir

http://www.w3.org/2001/XMLSchema#string

Oliver Kayes

http://www.w3.org/2001/XMLSchema#string

Suks Minhas

http://www.w3.org/2001/XMLSchema#string

P2860

Management of “Buried” Penis in Adulthood: An Overview

Bioengineered corporal tissue for structural and functional restoration of the penis

Consensus statement on management of intersex disorders

Congenital micropenis: long-term medical, surgical and psychosexual follow-up of individuals raised male or female

Severe hypospadias with genital ambiguity: adult outcome after staged hypospadias repair

A preliminary report of penile transplantation

Ethical issues in penile transplantation

Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate.

Organ-sparing treatment for penile cancer.

Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.

P2888

nrurol.2012.150

P304

499-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2012.150

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015036102

http://www.w3.org/2001/XMLSchema#string

P698

22890302

http://www.w3.org/2001/XMLSchema#string

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

about

P2860

P2860

Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698